Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort - PubMed (original) (raw)
Multicenter Study
. 2013 Mar-Apr;31(2 Suppl 76):31-6.
Epub 2013 Jul 22.
Veronica Codullo, Dilia Giuggioli, Valeria Riccieri, Giovanna Cuomo, Silvia Breda, Andreina Manfredi, Nicoletta Iannace, Michele D'Alto, Stefano Ghio, Rosario Rossi, Carmine Dario Vizza, Roberto Caporali, Guido Valesini, Clodoveo Ferri, Gabriele Valentini
Affiliations
- PMID: 23910607
Multicenter Study
Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort
Michele Iudici et al. Clin Exp Rheumatol. 2013 Mar-Apr.
Abstract
Objectives: This paper aims to investigate the prevalence, the incidence of pulmonary hypertension (PH) and its subtypes in Italian patients with systemic sclerosis (SSc) and to characterise features associated with and predictive of development of PH.
Methods: Eight-hundred and sixty-seven consecutive SSc patients recruited at 4 Italian centres were enrolled. At admission, all patients underwent a careful history, physical examination, EKG, lung high resolution computed tomography (HRCT), pulmonary function tests, B-mode echocardiography and right heart catheterisation (RHC), if indicated. Patients were then visited every 6-12 months. A RHC was performed in those patients in whom PH was suspected for the presence of pre-specified criteria.
Results: Among the 212 patients in whom it was suspected, PH was confirmed by RHC in 69 patients. On 31st December 2010, the point prevalence of P-arterial-H(PAH) and PH associated with interstitial lung disease (PH-ILD) was 3.7% and 1.4%, respectively; that of postcapillary PH was 1.3%. The estimated incidence rates of PH and PAH were respectively 1.85/100 patient-years and 1.02/100 patient-years. Multivariate analysis indicated that diffusing lung capacity for CO (DLCO) ≤55% (HR 4.45, 95%CI 2.24-8.83; p<0.001) and sPAP >40 mmHg (HR 18.03, 95%CI 9.01-36.06; p<0.001) were associated with an increased risk to develop PAH. SystolicPAP >40 mmHg resulted the only predictor of PH-ILD (HR 5.17, 95%CI 1.37-19.5; p=0.018) and post-capillary PH (HR 7.91, 95%CI 1.88-33.1; p=0.005) development.
Conclusions: Our study confirms a lower prevalence of PH in Italy compared to Anglo-Saxon cohorts. We also identified patients at high risk, who should be carefully monitored.
Similar articles
- Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
Launay D, Humbert M, Berezne A, Cottin V, Allanore Y, Couderc LJ, Bletry O, Yaici A, Hatron PY, Mouthon L, Le Pavec J, Clerson P, Hachulla E. Launay D, et al. Chest. 2011 Oct;140(4):1016-1024. doi: 10.1378/chest.10-2473. Epub 2011 Apr 7. Chest. 2011. PMID: 21474572 - Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies.
Avouac J, Airò P, Meune C, Beretta L, Dieude P, Caramaschi P, Tiev K, Cappelli S, Diot E, Vacca A, Cracowski JL, Sibilia J, Kahan A, Matucci-Cerinic M, Allanore Y. Avouac J, et al. J Rheumatol. 2010 Nov;37(11):2290-8. doi: 10.3899/jrheum.100245. Epub 2010 Sep 1. J Rheumatol. 2010. PMID: 20810505 - Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.
Choi JH, Joo SJ, Kim J. Choi JH, et al. Int J Rheum Dis. 2016 Jan;19(1):65-73. doi: 10.1111/1756-185X.12769. Epub 2015 Oct 7. Int J Rheum Dis. 2016. PMID: 26820839 - Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.
Proudman SM, Stevens WM, Sahhar J, Celermajer D. Proudman SM, et al. Intern Med J. 2007 Jul;37(7):485-94. doi: 10.1111/j.1445-5994.2007.01370.x. Intern Med J. 2007. PMID: 17547726 Review. - The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort.
Colalillo A, Hoffmann-Vold AM, Pellicano C, Romaniello A, Gabrielli A, Hachulla E, Smith V, Simeón-Aznar CP, Castellví I, Airò P, Truchetet ME, Siegert E, Distler O, Rosato E; EUSTAR collaborators. Colalillo A, et al. Autoimmun Rev. 2023 Apr;22(4):103290. doi: 10.1016/j.autrev.2023.103290. Epub 2023 Feb 4. Autoimmun Rev. 2023. PMID: 36746368 Review.
Cited by
- The Management of Mild Pulmonary Hypertension in Clinical Practice.
Zeder K, Brittain E, Kovacs G, Maron BA. Zeder K, et al. Ann Am Thorac Soc. 2024 Aug;21(8):1115-1123. doi: 10.1513/AnnalsATS.202312-1079FR. Ann Am Thorac Soc. 2024. PMID: 38747696 Review. - Systemic sclerosis cutaneous expression: Management of skin fibrosis and digital ulcers.
Starnoni M, Pappalardo M, Spinella A, Testoni S, Lattanzi M, Feminò R, De Santis G, Salvarani C, Giuggioli D. Starnoni M, et al. Ann Med Surg (Lond). 2021 Nov 2;71:102984. doi: 10.1016/j.amsu.2021.102984. eCollection 2021 Nov. Ann Med Surg (Lond). 2021. PMID: 34840747 Free PMC article. Review. - Incidence, predictors, and survival of pulmonary hypertension determined by echocardiography in Thai patients with early systemic sclerosis (SSc): inception cohort study.
Wangkaew S, Pota P, Prasertwittayakij N, Phrommintikul A. Wangkaew S, et al. Clin Rheumatol. 2021 Mar;40(3):973-980. doi: 10.1007/s10067-020-05296-w. Epub 2020 Jul 18. Clin Rheumatol. 2021. PMID: 32683661 - Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
Di Benedetto P, Guggino G, Manzi G, Ruscitti P, Berardicurti O, Panzera N, Grazia N, Badagliacca R, Riccieri V, Vizza CD, Radchenko G, Liakouli V, Ciccia F, Cipriani P, Giacomelli R. Di Benedetto P, et al. Arthritis Res Ther. 2020 Jun 1;22(1):127. doi: 10.1186/s13075-020-02218-8. Arthritis Res Ther. 2020. PMID: 32487240 Free PMC article. - Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study.
Butt SA, Jeppesen JL, Torp-Pedersen C, Sam F, Gislason GH, Jacobsen S, Andersson C. Butt SA, et al. J Am Heart Assoc. 2019 Sep 3;8(17):e013405. doi: 10.1161/JAHA.119.013405. Epub 2019 Aug 24. J Am Heart Assoc. 2019. PMID: 31446827 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical